S. Nakashima

Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis

S. Yamagishi, T. Matsui, S. Okuda, 2015, Laboratory Investigation.

Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis

S. Yamagishi, T. Matsui, M. Takeuchi, 2014, Hormone and Metabolic Research.

Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A.

S. Yamagishi, T. Matsui, Y. Nishino, 2012, Microvascular research.

Rosuvastatin restores advanced glycation end product-induced decrease in sirtuin 1 (SIRT1) mRNA levels in THP-1 monocytic cells through its anti-oxidative properties.

S. Yamagishi, T. Matsui, Y. Ishibashi, 2013, International journal of cardiology.

Pigment epithelium-derived factor (PEDF) blocks high glucose-induced inflammatory reactions in endothelial cells through its anti-oxidative properties.

S. Yamagishi, T. Matsui, S. Nakashima, 2013, International journal of cardiology.

Beneficial Effects of Vildagliptin on Retinal Injury in Obese Type 2 Diabetic Rats

S. Yamagishi, T. Matsui, Y. Yoshida, 2013, Ophthalmic Research.